Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 1, 2004; 10(1): 136-142
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Table 1 Clinico-pathological characteristics of 49 GI cancer patients
| Parameters | Treatment group(n = 25) | Control group(n = 24) |
| Age (y) | ||
| Mean (range) | 50 (25-73) | 53 (27-78) |
| Gender | ||
| Male | 13 | 16 |
| Female | 12 | 8 |
| Tumor sites | ||
| Stomach | 6 | 5 |
| Colon | 3 | 3 |
| Rectum | 16 | 16 |
| Pathological types | ||
| Tubular adenocarcinoma | 14 | 12 |
| Papillary adenocarcinoma | 3 | 3 |
| Villous adenocarcinoma | 2 | 1 |
| Signet-ring-cell carcinoma | 2 | 3 |
| Mucous adenocarcinoma | 4 | 5 |
| TNM stages | ||
| I | 3 | 5 |
| II | 7 | 9 |
| III | 9 | 6 |
| IV | 6 | 4 |
| Tumor differentiation | ||
| Well differentiated | 5 | 6 |
| Moderately differentiated | 8 | 7 |
| Poorly differentiated | 12 | 11 |
- Citation: Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol 2004; 10(1): 136-142
- URL: https://www.wjgnet.com/1007-9327/full/v10/i1/136.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i1.136